Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) currently has a daily average trading volume of 31.14K but it saw 24891902 shares traded in last market. With a market cap of 6.66M USD, the company’s current market price of $3.73 came falling about -11.40 while comparing to the previous closing price of $4.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $18.72 and as low as $4.00. In the recent trading on the day, stock has struck highest price mark of $3.4 while lowest mark touched by it was $10.0.
Taking a look at 20-day trading activity of Sonnet BioTherapeutics Holdings Inc (SONN) gives us an average price of $5.07, while its current price level is -80.07% below from 52-week high level whereas it is -6.75% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $5.87 while that of 200 days or SMA-200 reads an average of $10.27. A closer look into the stock’s movement over the week reveals that its volatility is standing at 44.74% during that period while stretching the period over a month that decreases to 20.75%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 30.55 which implies that the stock is in neutral territory.
Over the week, SONN’s stock price is moving -18.38% down while it is -23.57% when we observe its performance for the past one month. Year-to-date it is -73.20% down and over the past year, the stock is showing a downside performance of -66.46%.
Currently, Sonnet BioTherapeutics Holdings Inc’s total number of outstanding shares is 0.68M. Company’s return on investment (ROI) stands at -297.19% and return on equity (ROE) at -264.57%. Stock’s beta reads 0.53. Stock has a price to book (P/B) ratio of 0.93 while price to sale or P/S ratio amounts to 111.04. Its return on asset (ROA) is -100.88% on average.
